Dinutuximab beta plus chemotherapy shrinks neuroblastoma tumors in children
Children with a rare form of cancer called neuroblastoma which hasn’t responded to initial treatment or that has…
Triaptosis-based therapeutic innovations could offer renewed hope for cancer patients
Cancer remains one of the most critical global public health challenges, exerting profound social, economic, and clinical burdens…
Single-cell study reveals how HPV shapes immune landscape in penile cancer
Although penile cancer represents less than 1% of male malignancies, it carries substantial physical and psychological burden, with…
Researchers achieve long-term remission with novel T cell therapies for HPV-related cancers
Researchers from Rutgers Cancer Institute, New Jersey’s only National Cancer Institute (NCI) – designated Comprehensive Cancer Center, and…
New studies shine light on oral immunotherapy and oral food challenges in allergic children
Two new studies being presented at the American College of Allergy, Asthma and Immunology (ACAAI) Annual Scientific Meeting…
Study reveals how melanoma evolves to resist immunotherapy
A study led by UCLA Health Jonsson Comprehensive Cancer Center investigators reveals how melanoma, the deadliest form of skin cancer,…
Lactate and lactylation drive metabolic, epigenetic reprogramming in gynecological cancers
Lactate, once considered a metabolic waste product, is now recognized as a key regulator of cellular homeostasis and…
A GP guide to molecular testing in lung cancer
Need to know: Lung cancer remains a significant health challenge in Australia, being the fifth most commonly diagnosed…
Having children and breastfeeding reduces breast cancer risk by triggering immune system, study finds
One of the earliest clues that having children may help to protect women against breast cancer came from…
CRATERs identified as key sites for T cell-mediated tumor destruction
Like the surface of the moon, new research published today in Cell finds the existence of craters on…
Lung cancer researchers identify ‘breakthrough’ patterns predictive of treatment success
Researchers have discovered a way to predict whether patients with lung cancer will respond to expensive immunotherapy treatment…
Early trial finds promise for avelumab and radiation in treating leptomeningeal disease
Researchers at Moffitt Cancer Center have reported encouraging results from a phase 1B clinical trial showing that the…